Publikationen von K. H. Schlingensiepen

Rifai, A.; Brysch, W.; Fadden, K.; Clark, J.; Schlingensiepen, K. H.: Clearance kinetics, biodistribution, and organ saturability of phosphorothioate oligodeoxynucleotides in mice. American Journal of Pathology 149 (2), S. 717 - 725 (1996)

Zurmoehle, U.; Herms, J.; Schlingensiepen, R.; Brysch, W.; Schlingensiepen, K. H.: Changes in the expression of synapsin I and II messenger RNA during postnatal rat brain development. Experimental Brain Research 108 (3), S. 441 - 449 (1996)

Jachimczak, P.; Hessdorfer, B.; Fabel-Schulte, K.; Wismeth, C.; Brysch, W.; Schlingensiepen, K. H.; Bauer, A.; Blesch, A.; Bogdahn, U.: Transforming growth factor-beta-mediated autocrine growth regulation of gliomas as detected with phosphorothioate antisense oligonucleotides. International Journal of Cancer 65 (3), S. 332 - 337 (1996)

Jachimczak, P.; Fabel-Schulte, K.; Hessdorfer, B.; Brysch, W.; Schlingensiepen, K. H.; Blesch, A.; Bogdahn, U.: Transforming growth factor-β-mediated regulation of human peripheral blood mononuclear cell proliferation as detected with phosphorothioate antisense oligodeoxynucleotides. Cellular Immunology 165 (1), S. 125 - 133 (1995)

Rother, S.; Schmidt, R.; Brysch, W.; Schlingensiepen, K. H.: Learning-induced expression of meningeal ependymin mRNA and demonstration of ependymin in neurons and glial cells. Journal of Neurochemistry 65 (4), S. 1456 - 1464 (1995)

Schmidt, R.; Brysch, W.; Rother, S.; Schlingensiepen, K. H.: Inhibition of memory consolidation after active avoidance conditioning by antisense intervention with ependymin gene expression. Journal of Neurochemistry 65 (4), S. 1465 - 1471 (1995)

Paulus, W.; Baur, I.; Huettner, C.; Schmausser, B.; Roggendorf, W.; Schlingensiepen, K. H.; Brysch, W.: Effects of transforming growth factor-[beta]1 on collagen synthesis, integrin expression, adhesion an invasion of glioma cells. Journal of Neuropathology and Experimental Neurology 54 (2), S. 236 - 244 (1995)

Wollnik, F.; Brysch, W.; Uhlmann, E.; Gillardon, F.; Bravo, R.; Zimmermann, M.; Schlingensiepen, K. H.; Herdegen, T.: Block of c-Fos and JunB expression by antisense oligonucleotides inhibits light-induced-phase shifts of the mammalian circadian clock. European Journal of Neuroscience 7 (3), S. 388 - 393 (1995)

Bertram, J.; Palfner, K.; Killian, M.; Brysch, W.; Schlingensiepen, K. H.; Hiddemann, W.; Kneba, M.: Reversal of multiple drug resistance in vitro by phosphorathioate oligonucleotides and ribozymes. Anti-Cancer Drugs 6 (1), S. 124 - 134 (1995)

Schlingensiepen, R.; Terlau, H.; Brysch, W.; Schlingensiepen, K. H.: Differential expression of c-jun, junB, and junD in rat hippocampal slices. NeuroReport 6 (1), S. 101 - 104 (1994)

Brysch, W.; Schlingensiepen, K. H.: Design and application of antisense oligonucleotides in cell culture in vivo and as therapeutic agents. Cellular and Molecular Neurobiology 14 (5), S. 557 - 568 (1994)

Schlingensiepen, K. H.; Wollnik, F.; Kunst, M.; Schlingensiepen, R.; Herdegen, T.; Brysch, W.: The role of Jun transcription factor expression and phosphorylation in neuronal differentiation, neuronal cell death, and plastic adaptations in vivo. Cellular and Molecular Neurobiology 14 (5), S. 487 - 505 (1994)

Tischmeyer, W.; Grimm, R.; Schicknick, H.; Brysch, W.; Schlingensiepen, K. H.: Sequence specific impairment of learning by C-jun antisense oligonucleotides. NeuroReport 5 (12), S. 1501 - 1504 (1994)

Brysch, W.; Magal, E.; Louis, J. C.; Kunst, M.; Klinger, I.; Schlingensiepen, R.; Schlingensiepen, K. H.: Inhibition of P185(C-ERBB-2) protooncogene expression by antisense oligodeoxynuleotides down regulates P185 associated tyrosine kinase activity and strongly inhibits mammary tumor cell proliferation. Cancer Gene Therapy 1 (2), S. 99 - 105 (1994)

Zurmoehle, U.; Herms, J.; Schlingensiepen, R.; Schlingensiepen, K. H.; Brysch, W.: Changes of synapsin I messenger RNA expression during rat brain development. Experimental Brain Research 99 (1), S. 17 - 24 (1994)

Bertram, J.; Killian, M.; Brysch, W.; Schlingensiepen, K. H.; Kneba, M.: Reduction of erbB2 gene-product in mamma carcinoma cell lines by erbB2 mRNA-specific and tyrosine kinase consensus phosphorothioate antisense oligonucleotides. Biochemical and Biophysical Research Communications 200 (1), S. 661 - 667 (1994)

Herms, J.; Zurmoehle, U.; Schlingensiepen, R.; Brysch, W.; Schlingensiepen, K. H.: Developmental expression of the transcription factor zif268 in rat brain. Neuroscience Letters 165 (1-2), S. 171 - 174 (1994)

Schlingensiepen, K. H.; Brysch, W.; Grimm, R.; Schicknick, H.; Tischmeyer, W.: Antisense oligonucleotides may affect processes involved in learning and memory in a sequence specific manner. Journal of Neurochemistry 63 (Suppl. Suppl. 1), S. S15 - S15 (1994)

Schlingensiepen, K. H.; Herdegen, T.; Wollnik, F.; Schicknick, H.; Tischmeyer, W.; Brysch, W.: Alterations of neuronal differentiation in vitro and of animal behavior in vitro after selective gene with antisense oligonucleotides. Journal of Neurochemistry 63 (Suppl. Suppl. 1), S. S67 - S67 (1994)

Schmidt, R.; Rother, S.; Brysch, W.; Schlingensiepen, K. H.: Rapid induction of ependymin messenger-RNA after active avoidance conditioning and antisense intervention with memory consolidation. Journal of Neurochemistry 63 (Suppl. Suppl. 1), S. S67 - S67 (1994)